Edwards Lifesciences | EW - 普通股股本

股票价格

81.39

每天变化

0.05 0.06%

每月一次

2.96%

每年

4.35%

Q2 预测

78.30

金融业

USD

USD 13.32B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.23B

USD 1.41B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.33B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 48.39B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.12B

贸易债权人

USD 181.1M

应收帐款人

USD 912.1M

	普通股股本	更改		日
Abbott	USD 1.74B		23.39B	2025-09
Artivion	USD 47.84M		468K	2025-12
AtriCure	USD 49.79M		91K	2025-12
Baxter International	USD 516.45M		2.17M	2026-03
Becton, Dickinson and Co.	USD 284.91M		1.72M	2025-12
Boston Scientific	USD 1.48B		2.66M	2025-12
Cooper Companies	USD 195.1M		3.71M	2025-12
Dexcom	USD 385.9M		1.1M	2026-03
Edwards Lifesciences	USD 580.7M		0	2025-12
Globus Medical	USD 135.06M		449K	2025-12
ICU Medical	USD 24.69M		2K	2025-12
Inogen	USD 23K		0	2023-12
Insulet	USD 69.26M		1.08M	2026-03
Integra LifeSciences	USD 77.82M		69K	2026-03
Intuitive Surgical	USD 355.17M		674K	2026-03
J&J	USD 2.41B		1.74M	2025-12
Masimo	USD 52.4M		300K	2026-03
Medtronic	USD 1.28B		1.38M	2025-12
Merit Medical Systems	USD 59.65M		231K	2026-03
Stryker	USD 382.98M		584K	2026-03
Tandem Diabetes Care	USD 68.29M		518K	2025-12
Teleflex	USD 44.26M		70K	2026-03
Zimmer Biomet Holdings	USD 195.5M		2.68M	2026-03